Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 30, 2016 - Issue 11
216
Views
12
CrossRef citations to date
0
Altmetric
Articles

Harpagophytum procumbens extract potentiates morphine antinociception in neuropathic rats

, , , &
Pages 1248-1255 | Received 19 Mar 2015, Accepted 11 May 2015, Published online: 20 Jul 2015

References

  • Abdelouahab N, Heard C. 2008. Effect of the major glycosides of Harpagophytum procumbens (Devil's Claw) on epidermal cyclooxygenase-2 (COX-2) in vitro. J Nat Prod. 71:746–749.
  • Anauate MC, Torres LM, de Mello SB. 2010. Effect of isolated fractions of Harpagophytum procumbens D.C. (devil's claw) on COX-1, COX-2 activity and nitric oxide production on whole-blood assay. Phytother Res. 24:1365–1369.
  • Andersen ML, Santos EHR, Seabra Maria de Lourdes V, da Silva AAB, Tufik S. 2004. Evaluation of acute and chronic treatments with Harpagophytum procumbens on Freund's adjuvant-induced arthritis in rats. J Ethnopharmacol. 91:325–330.
  • Argoff C. 2011. Mechanisms of pain transmission and pharmacologic management. Curr Med Res Opin. 27:2019–2031.
  • Baghdikian B, Lanhers MC, Fleurentin J, Ollivier E, Maillard C, Balansard G, Mortier F. 1997. An analytical study, anti-inflammatory and analgesic effects of Harpagophytum procumbens and Harpagophytum zeyheri. Planta Med. 63:171–176.
  • Basbaum AI, Bautista DM, Scherrer G, Julius D. 2009. Cellular and molecular mechanisms of pain. Cell. 139:267–284.
  • Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, Glaser SE, Vallejo R. 2008. Opioid complications and side effects. Pain Phys. 11:S105–S120.
  • Bhattacharya A, Bhattacharya S. 1998. Anti-oxidant activity of Harpagophytum procumbens. Br J Phytother. 5:68–71.
  • Déciga-Campos M, Lopez UG, Diaz Reval MI, Lopez-Munoz FJ. 2003. Enhancement of antinociception by co-administration of an opioid drug (morphine) and a preferential cyclooxygenase-2 inhibitor (rofecoxib) in rats. Eur J Pharmacol. 460:99–107.
  • Dugas, Jr, AJ, Castaneda-Acosta J, Bonin GC, Price KL, Fischer NH, Winston GW. 2000. Evaluation of the total peroxyl radical-scavenging capacity of flavonoids: structure–activity relationships. J Nat Prod. 63:327–331.
  • Fiebich BL, Heinrich M, Hiller K-O, Kammerer N. 2001. Inhibition of TNF-alpha synthesis in LPS-stimulated primary human monocytes by Harpagophytum extract SteiHap 69. Phytomedicine. 8:28–30.
  • Fiebich BL, Muñoz E, Rose T, Weiss G, McGregor GP. 2012. Molecular targets of the antiinflammatory Harpagophytum procumbens (devil's claw): inhibition of TNFα and COX-2 gene expression by preventing activation of AP-1. Phytother Res. 26:806–811.
  • Galluzzi KE. 2005. Management of neuropathic pain. J Am Osteop Assoc. 105:S12–S19.
  • Georgiev MI, Ivanovska N, Alipieva K, Dimitrova P, Verpoorte R. 2013. Harpagoside: from Kalahari Desert to pharmacy shelf. Phytochemistry. 92:8–15.
  • Grant L, McBean DE, Fyfe L, Warnock AM. 2007. A review of the biological and potential therapeutic actions of Harpagophytum procumbens. Phytother Res. 21:199–209.
  • Hostanska K, Melzer J, Rostock M, Suter A, Saller R. 2014. Alteration of anti-inflammatory activity of Harpagophytum procumbens (devil's claw) extract after external metabolic activation with S9 mix. J Pharm Pharmacol. 66:1606–1614.
  • Huang TH, Tran VH, Duke RK, Tan S, Chrubasik S, Roufogalis BD, Duke CC. 2006. Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-kappa B activation. J Ethnopharmacol. 104:149–155.
  • Ji RR, Strichartz G. 2004. Cell signaling and the genesis of neuropathic pain. Science's STKE Sig Trans Knowledge Environ. 252:reE14.
  • Kaszkin M, Beck KF, Koch E, Erdelmeier C, Kusch S, Pfeilschifter J, Loew D. 2004. Downregulation of iNOS expression in rat mesangial cells by special extracts of Harpagophytum procumbens derives from harpagoside-dependent and independent effects. Phytomedicine. 11:585–595.
  • Khan MIA, Walsh D, Brito-Dellan N. 2011. Opioid and adjuvant analgesics: compared and contrasted. Am J Hosp Palliat Care. 28:378–383.
  • Kim HK, Park SK, Zhou J-L, Taglialatela G, Chung K, Coggeshall RE, Chung JM. 2004. Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain. Pain. 111:116–124.
  • Kundu JK, Mossanda KS, Na H-K, Surh Y-J. 2005. Inhibitory effects of the extracts of Sutherlandia frutescens (L.) R. Br. and Harpagophytum procumbens DC. on phorbol ester-induced COX-2 expression in mouse skin: AP-1 and CREB as potential upstream targets. Cancer Lett. 218:21–31.
  • Lim DW, Kim JG, Han D, Kim YT. 2014. Analgesic effect of Harpagophytum procumbens on postoperative and neuropathic pain in rats. Molecules. 19:1060–1068.
  • Mahomed IM, Ojewole JA. 2004. Analgesic, antiinflammatory and antidiabetic properties of Harpagophytum procumbens DC (Pedaliaceae) secondary root aqueous extract. Phytother Res. 18:982–989.
  • McGregor G, Fiebich B, Wartenberg A, Brien S, Lewith G, Wegener T. 2005. Devil's Claw (Harpagophytum procumbens): an anti-inflammatory herb with therapeutic potential. Phytochem Rev. 4:47–53.
  • Mncwangi N, Chen W, Vermaak I, Viljoen AM, Gericke N. 2012. Devil's Claw-a review of the ethnobotany, phytochemistry and biological activity of Harpagophytum procumbens. J Ethnopharmacol. 143:755–771.
  • Na H-K, Mossanda KS, Lee J-Y, Surh Y-J. 2004. Inhibition of phorbol ester-induced COX-2 expression by some edible African plants. Biofactors. 21:149–153.
  • Orrù A, Marchese G, Casu G, Casu MA, Kasture S, Cottiglia F, Acquas E, Mascia MP, Anzani N, Ruiu S. 2014. Withania somnifera root extract prolongs analgesia and suppresses hyperalgesia in mice treated with morphine. Phytomedicine. 21:745–752.
  • Parenti C, Turnaturi R, Arico G, Gramowski-Voss A, Schroeder OH-U, Marrazzo A, Prezzavento O, Ronsisvalle S, Scoto GM, Ronsisvalle G, Pasquinucci L. 2013. The multitarget opioid ligand LP1's effects in persistent pain and in primary cell neuronal cultures. Neuropharmacology. 71:70–82.
  • Pasternak G, Pan YX. 2011. Mu opioid receptors in pain management. Acta Anaesthesiol Taiwan. 49:21–25.
  • Redondo-Castro E, Navarro X. 2014. Chronic ibuprofen administration reduces neuropathic pain but does not exert neuroprotection after spinal cord injury in adult rats. Exp Neurol. 252:95–103.
  • Romero-Sandoval EA, Horvath RJ, DeLeo JA. 2008. Neuroimmune interactions and pain: focus on glial-modulating targets. Curr Opin Invest Drugs. 9:726–734.
  • Sandkühler J. 2009. Models and mechanisms of hyperalgesia and allodynia. Physiol Rev. 89:707–758.
  • Sawa T, Nakao M, Akaike T, Ono K, Maeda H. 1999. Alkylperoxyl radical- scavenging activity of various flavonoids and other phenolic compounds: implications for the anti-tumor-promoter effect of vegetables. J Agric Food Chem. 47:397–402.
  • Schaffer LF, Peroza LR, Boligon AA, Athayde ML, Alves SH, Fachinetto R, Wagner C. 2013. Harpagophytum procumbens prevents oxidative stress and loss of cell viability in vitro. Neurochem Res. 38:2256–2267.
  • Uchida S, Hirai K, Hatanaka J, Hanato J, Umegaki K, Yamada S. 2008. Antinociceptive effects of St. John's wort, Harpagophytum procumbens extract and Grape seed proanthocyanidins extract in mice. Biol Pharm Bull. 31:240–245.
  • Volk OH. 1953. The complete German Commission Monographs. Boston (MA): Published in cooperation with the Integrative Medicine Communications; p. 249.
  • Zelcer S, Kolesnikov Y, Kovalyshyn I, Pasternak DA, Pasternak GW. 2005. Selective potentiation of opioid analgesia by nonsteroidal anti-inflammatory drugs. Brain Res. 1040:151–156.
  • Zorn B. 1958. Zeitschrift Rheumaforschung [Antiarthritis effect of the Harpagophytum root]. Preliminary Report. 17:134–138.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.